Compare

NewcelX Ltd. vs Revelation Biosciences, Inc. vs MetaVia Inc. vs Decoy Therapeutics Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal year	NewcelX Ltd. NCEL	Revelation Biosciences, Inc. REVB	MetaVia Inc. MTVA	Decoy Therapeutics Inc. DCOY
Year ended	2025-12-31	2025-12-31	2025-12-31	2025-12-31
Revenue	n/a	n/a	n/a	n/a
Revenue growth (YoY)	n/a	n/a	n/a	n/a
Gross margin	n/a	n/a	n/a	n/a
Operating margin	n/a	n/a	n/a	n/a
Net margin	n/a	n/a	n/a	n/a
Net income	-$8.30M	-$8.91M	-$12.97M	-$12.52M
EPS (Diluted)	$2.16	-$23.95	-$7.35	-$129.10
Operating cash flow	-$2.77M	-$8.27M	-$15.70M	-$4.83M
Free cash flow	-$2.77M	n/a	-$15.70M	-$5.40M
Cash & equivalents	$2.20M	$10.70M	$10.28M	$10.71M
Total assets	$11.45M	$11.58M	$11.12M	$11.06M
Total liabilities	$4.20M	$2.72M	$5.79M	$5.17M
Shareholders' equity	$7.25M	$8.86M	$5.33M	$5.89M
Return on year-end equity	-114.5%	-100.6%	-243.3%	-212.6%
Shares outstanding	4.80M	1.58M	2.31M	n/a

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal year	NewcelX Ltd.	Revelation Biosciences, Inc.	MetaVia Inc.	Decoy Therapeutics Inc.
Latest	n/a	n/a	n/a	$0 Ended 2022-12-31
1 year earlier	n/a	n/a	n/a	$1.84M Ended 2021-12-31
2 years earlier	n/a	n/a	n/a	$5.23M Ended 2020-12-31
3 years earlier	n/a	n/a	n/a	$3.47M Ended 2019-12-31
4 years earlier	n/a	n/a	n/a	$1.95M Ended 2018-12-31